Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis
Angiotensin-converting enzyme 2 (ACE2), a key regulator in vasoregulation and the renin-angiotensin system, is hypothesized to be downregulated in patients with COVID-19, leading to a cascade of cardiovascular complications. This deactivation potentially results in increased blood pressure and vesse...
Saved in:
Main Authors: | Christina-Michailia Sideratou (Author), Christos Papaneophytou (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems
by: Christina-Michailia Sideratou, et al.
Published: (2023) -
The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Jean M. Nunes, et al.
Published: (2022) -
Advances in Catalyst Deactivation
by: Calvin H. Bartholomew (Ed.)
Published: (2016) -
The role of ACE inhibitor in reducing persistent proteinuria in nephrotic syndrome
by: Erika Hutabarat, et al.
Published: (2002) -
Catalysts Deactivation, Poisoning and Regeneration
by: Lisi, Luciana
Published: (2019)